Colon Cancer News

HealthDay - WEDNESDAY, Nov. 14 (HealthDay News) -- A highly targeted biologic drug called cetuximab (Erbitux) is the first to extend the survival of patients with advanced colon cancer who have otherwise proved resistant to conventional chemotherapy, Canadian researchers confirmed.

Reuters - Colonoscopy is recommended as a screening test for colon cancer and now new research shows that it is useful in predicting the development of advanced tumors. This information may help doctors determine how often follow-up colonoscopy should be performed.

HealthDay - FRIDAY, Oct. 26 (HealthDay News) -- Sixty-three percent of American women think that if there's no family history of cancer, you're not likely to develop the disease, a new survey found.

Sixty-three percent of American women think that if there's no family history of cancer, you're not likely to develop the disease, a new survey found.

HealthDay - WEDNESDAY, Oct. 24 (HealthDay News) -- The addition of the chemotherapy drug, docetaxel, to the standard two-drug regimen used for head and neck cancers improved the efficacy of the treatment while reducing the toxicity, two new studies report.

Reuters - An analysis of the results of several studies confirm previous reports suggesting that chemotherapy offers little or no survival benefits for young women with estrogen receptor (ER)-positive breast cancers and, if given, it should not be the sole second-phase, or "adjuvant" therapy.

The United States isn't making the grade when it comes to women's health, a new report contends.

American Cancer Society - The cancer death rate in the United States -- which has been slowly dropping since 1993 -- has fallen even more significantly in recent years, according to an annual report from the nation's leading cancer organizations.

HealthDay - TUESDAY, Oct. 16 (HealthDay News) -- A first-time colonoscopy to remove precancerous polyps plays a bigger role in reducing the risk of dying from colon cancer than do follow-up screenings done years later, a new study suggests.

A first-time colonoscopy to remove precancerous polyps plays a bigger role in reducing the risk of dying from colon cancer than do follow-up screenings done years later, a new study suggests.

HealthDay - MONDAY, Oct. 15 (HealthDay News) -- Death rates from cancer are dropping more quickly across the United States, offering what an expert called a "glimmer of hope" against a leading killer.

Death rates from cancer are dropping more quickly across the United States, offering what an expert called a "glimmer of hope" against a leading killer.

AP - Good news on the cancer front: Death rates are dropping faster than ever, thanks to new progress against colorectal cancer.

Reuters - Obesity is an important risk factor for colorectal cancer in women, perhaps more important than smoking, according to research presented this week in Philadelphia.

American Cancer Society - The cancer death rate in the United States -- which has been slowly dropping since 1993 -- has fallen even more significantly in recent years, according to an annual report from the nation's leading cancer organizations.

Two recent studies comparing the use of conventional (optical) colonoscopy and CT (virtual) colonoscopy for colorectal cancer screening may raise questions among people considering the test, says the American College of Gastroenterology (ACG).

AP - Having an X-ray to look for signs of colon cancer may soon be an option for those who dread the traditional scope exam. Two of the largest studies yet of "virtual colonoscopy" show the experimental technique works just as well at spotting potentially cancerous growths as the more invasive method. It's also quicker and cheaper.

A new study supports the effectiveness of an innovative form of colonoscopy that relies on a CT scanner that's sent through a patient's colon.

Although eating lots of fruits and vegetables is good for your health, doing so will not reduce your risk for colon cancer, a Canadian study finds.

A new generation of fecal blood tests can screen for colon cancer with unprecedented accuracy, researchers report.